Agilent reorganizes segments into Life Sciences & Diagnostics Markets, Agilent CrossLab, Applied Markets

AGILENT TECHNOLOGIES, INC.

Former Diagnostics & Genomics merged with LC/MS platforms into Life Sciences and Diagnostics Markets segment.
Chemistries, supplies, lab automation, software, informatics moved to Agilent CrossLab segment.
GC/MS, spectroscopy, vacuum divisions form new Applied Markets segment.
Recast of 2024 10-K Items 1, 2, 7, 8 reflects new segments; no change to audited financials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.